Tucson, AZNCT07407582Now EnrollingIRB Ready

Solid Tumor Malignancies Clinical Trial in Tucson, AZ

Access cutting-edge solid tumor malignancies treatment through this phase 1/2 clinical trial at a research site in Tucson. Study-provided care at no cost to qualified participants.

Sponsored by University of Arizona

Quick Self-Assessment

See if you qualify for this Tucson location

Preparing your pre-screening questions…

Expert Care in Tucson

Access solid tumor malignancies specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related solid tumor malignancies treatment provided free

Apply for This Tucson Location

Check if you qualify for this solid tumor malignancies clinical trial in Tucson, AZ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Tucson

    Convenient for AZ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Tucson site if eligible
  4. 4Begin participation

About This Solid Tumor Malignancies Study in Tucson

The purpose of this study is to assess the safety and effectiveness of a drug called Pedmark® sodium thiosulfate (STS) in reducing hearing impairment with standard of care cisplatin therapy. The safety and effectiveness of STS in reducing hearing loss has been well established in children and is approved for use in the pediatric and young adult population. However, information in adult patients is limited. As most cisplatin is administered in the adult population, this investigation would be of benefit.

Sponsor: University of Arizona

Who Can Participate

Inclusion Criteria

Participants have provided informed consent prior to initiation of any study-specific activities.
At least 18 years of age, male or female, at the time of signing the informed consent.
ECOG Performance Status 0-1
Histologically or cytologically confirmed treatment-naïve cancer.
Scheduled to receive an FDA-approved, on-label indication, standard of care systemic cisplatin-based regimen (at least 200 mg/m2 cumulative dose) for any untreated any solid malignancy deemed by the treating physician

Exclusion Criteria

Prior cisplatin exposure due to a cancer treatment history
Concurrent ototoxic medication unable to be safely discontinued or switched to a non-toxic alternative
Planned radiation to the head or neck prior to, during, or within 3 months of completion of cisplatin
History of severe hypersensitivity to sulfite, sodium thiosulfate, or any components
Baseline serum sodium \> 145 mmol/L or any grade ≥ 3 electrolyte abnormality
Cisplatin infusion duration greater than 6 hours
Females during pregnancy or breastfeeding, and childbearing potential, unwilling to use a method of contraception during treatment
Male subjects with a pregnant partner who are unwilling to practice abstinence or use a condom during treatment
Subject likely not to be available to complete all protocol-required study visits or procedures, and/or to comply with all required study procedures (i.e., Clinical Outcome Assessments) to the best of the subject's and investigator's knowledge.
History or evidence of any other clinically significant disorder, condition, or disease (with the exception of those outlined above) that, in the opinion of the investigator, if consulted, would pose a risk to subject safety or interfere with the study evaluation, procedures, or completion.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Tucson?

Yes, this clinical trial (NCT07407582) has an active research site in Tucson, AZ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Solid Tumor Malignancies Treatment Options in Tucson, AZ

If you're searching for solid tumor malignancies treatment options in Tucson, AZ, this clinical trial (NCT07407582) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Tucson research site is actively enrolling participants for this phase 1/2 clinical trial. You'll receive care from experienced solid tumor malignancies specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all solid tumor malignancies clinical trials near you to find additional studies recruiting in your area.

More Advanced Solid Tumors Trials in Tucson, AZ

See all advanced solid tumors clinical trials recruiting in Tucson — not just this study.

Browse Advanced Solid Tumors Trials in Tucson →

Browse More Trials by Condition

Advanced Solid Tumors TrialsAll Conditions →

Ready to Join in Tucson?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Tucson, AZ